Celltrion is expanding its market presence in Peru, a key Latin American market, with successful public tender wins.Celltrion’s Truxima 500mg (rituximab) won the tender for the Peruvian Ministry of Health (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud, CENARES), the largest pub
Dong-A ST and IMBiologics said they have entered into a research collaboration agreement to develop a novel antibody drug candidate.The collaboration involves IMBiologics deploying its ePENDY (enhanced/engineered Pentamer body) platform technology.Unlike the conventional IgG antibody-based modalitie
Korean bio ventures are increasingly withdrawing their initial public offerings (IPOs) voluntarily after the stock market regulator Korea Exchange (KRX) has taken steps to implement a more rigorous review process.Most recently, Pinotbio voluntarily withdrew its Kosdaq listing plan on Wednesday, nine
SK chemicals said that it has decided not to proceed with the sale of its pharmaceutical business unit despite having previously signed a non-binding memorandum of understanding (MOU) with Glanwood Private Equity.SK chemicals' business divisions are divided into green chemicals, which produces eco-f
A research team at the Catholic University of Korea College of Medicine has recently identified a protein called Nuclear Receptor Coactivator 6 (NCOA6) as a potential inducer of gouty arthritis in joint macrophages, the primary cells responsible for innate immunity.The team, led by Professor Kim Wan
In a bid to address the looming crisis facing Korea's stroke treatment system, Korean Stroke Society (KSS) held a press conference at the Westin Josun Seoul aimed to dissect the current state of stroke care in the country and propose strategies to strengthen the healthcare infrastructure, especially
A study by researchers at Seoul National University Bundang Hospital (SNUBH) showed that the use of digital healthcare among older adults is poor, with half of the participants unable to install related applications despite smartphone use.Digital healthcare technology, including a wide range of heal
In a notable legal development, Hugel has secured a favorable outcome in its legal battles against the Ministry of Food and Drug Safety (MFDS) regarding the indirect export of Botulax, its botulinum toxin (BTX) products, which led to the revocation of its sales license. The Seoul Administrative Cour
Samsung Biologics said it has obtained the "Leadership A-"grade, the second highest of the eight grades, from Carbon Disclosure Project (CDP), a global sustainability assessment organization, for its climate change response efforts in 2023.The company stressed that it is the first in the domestic bi
Handok said it decided to establish a local joint venture with Swedish Orphan Biovitrum (Sobi), a global biopharmaceutical company specializing in rare diseases, in the first half of this year.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments i
Hugel said it showcased new clinical findings for its botulinum toxin (BTX) product at the 25th International Master Course on Aging Science (IMCAS) World Congress, held in Paris, France, from Feb. 1 to 3.The event, which is recognized as the world's largest conference on aesthetic plastic surgery,
Celltrion said it has completed its application for marketing authorization to the European Medicines Agency (EMA) for CT-P47, a biosimilar referencing Actemra.Roche's Actemra (ingredient: tocilizumab), known as RoActemra in Europe, is approved for a wide range of conditions, including rheumatoid ar
Severance Hospital has succeeded in conducting Korea's first irreversible electroporation surgery technique on a 76-year-old liver cancer patient. The patient has since been discharged and is now resuming normal daily activities.IRE involves creating small gaps of about 2mm in the cancerous tissue b
OCI Holdings Chairman Lee Woo-hyun has reaffirmed the company's strategy to play a minimal role in the management of Hanmi Group following the upcoming integration with Hanmi Science.During an investor conference call on Wednesday, Chairman Lee stated that OCI Holdings intends to support Hanmi Group
Yuhan Corp. said it posted highest-ever annual sales in 2023 thanks to technology export revenue.The company reported consolidated sales and operating profit of 1.8 trillion won ($1.3 billion) and 56.7 billion won in 2023, up 4.7 percent and 57.6 percent year-on-year. Net profit also jumped 57.4 per
The Seoul High Court on Wednesday upheld the lower court's decision, rejecting Kolon Life Science's appeal to suspend the Ministry of Food and Drug Safety's order cancelling the approval for Invossa-K, a gene therapy for osteoarthritis.This decision marks the second defeat for Kolon Life Science in
Researchers at Seoul National University Bundang Hospital (SNUBH) have successfully developed and demonstrated a groundbreaking technology that expedites skin wound healing devoid of antibiotics, leveraging metal-organic frameworks (MOFs).Antibiotics have undeniably been instrumental in prolonging h
Bayer Korea said it has entered into a strategic partnership with Chong Kun Dang to co-market Kerendia (ingredienet: finerenone), Bayer's novel treatment for chronic kidney disease (CKD) in patients with type 2 diabetes.Kerendia received approval from the Ministry of Food and Drug Safety in May 2022
Samsung Biologics has announced a collaborative venture into the development of antibody-drug conjugate (ADC) therapies by signing a new contract development organization (CDO) agreement with LegoChem Biosciences, a Korean ADC developer.Under the accord, Samsung Biologics will participate in the ess
The Ministry of Health and Welfare's announcement on Tuesday to increase medical school admissions by 2,000 students from the 2025 academic year has sparked a major backlash from doctors.This marks the most significant expansion in medical education capacity in 27 years, elevating the current quota